While this persistence rate is a marked improvement over the 10% observed for obesity-indicated GLP-1s, it still leaves 76% of potential demand unrealized
Specifically, tirzepatide enhances insulin release in response to high blood glucose levels while decreasing glucagon secretion , which helps lower blood sugar levels
If it hasnt, reach out to your employers Human Resources department or benefits coordinator and ask if Zepbound can be added to your coverage
Stop use and consult a healthcare provider if you experience severe allergic reactions (difficulty breathing, significant swelling, hives spreading beyond the injection site), chest pain or palpitations, severe or persistent gastrointestinal symptoms, or any symptom that concerns you significantly
Myth 3: GLP-1 Medications Cause Permanent Stomach Damage A common worry about GLP-1 medications is that they might cause lasting harm to your digestive system
Understanding what PT-141 isand what it isntis the first step in deciding if its a good fit for you